«上一篇/Previous Article|本期目录/Table of Contents|下一篇/Next Article»

《中华肺部疾病杂志》[ISSN:1006-6977/CN:61-1281/TN]

卷:

期数:

2025年01期

页码:

15-22

栏目:

论著

出版日期:

2025-02-25

文章信息/Info

Title:

Clinical analysis of doxycycline combined with levofloxacin for the treatment of Acinetobacter Baumannii pneumonia

作者:

庞茜茜; 刘云宁; 刘 斐; 赵学萍; 胡亚丽; 刘克勤

075000 张家口,河北北方学院附属第一医院药学部

Author(s):

Pang Qianqian;  Liu Yunning;  Liu Fei;  Zhao Xueping;  Hu Yali;  Liu Keqin.

Department of Pharmacy, The First Affiliated Hospital of Hebei North University, Zhangjiakou 075000, China

关键词:

大鼠;  肺炎; 耐碳青霉烯类鲍曼不动杆菌;  多西环素;  左氧氟沙星;  高温需求因子A2;  耐药性

Keywords:

Rats;  Carbapenem-resistant Acinetobacter baumannii pneumonia;  Doxycycline;  Levofloxacin;  High-temperature requirement factor A2;  Drug resistance

分类号:

R563.1

DOI:

10.3877/cma.j.issn.1674-6902.2025.01.003

摘要:

目的 分析多西环素联合左氧氟沙星调控高温需求因子A2(high temperature requirement factor A2, HtrA2)治疗耐碳青霉烯类鲍曼不动杆菌(Carbapenem-resistant Acinetobacter Baumannii, CRAB)肺炎的机制。方法 选择60只SD大鼠,随机分为对照组、模型组、多西环素组、左氧氟沙星组、联合组、过表达(overexpressed, oe)-HtrA2组,每组10只。模型组使用100 μl 1×10¹¹ cfu/L AB5075菌液滴入大鼠鼻腔; 多西环素组在模型组基础上使用20 mg/kg多西环素灌胃给药; 左氧氟沙星组在模型组基础上使用30 mg/kg左氧氟沙星灌胃给药; 联合组在模型组基础上使用20 mg/kg多西环素+30 mg/kg左氧氟沙星混合灌胃给药; oe-HtrA2组采用HtrA2慢病毒经尾静脉注射SD大鼠体内,每次200 μl 1×10⁹ IFU/L。采用实时荧光定量聚合酶链反应检测HtrA2 mRNA表达; 采用菌落形成单位法检测肺组织细菌含量; 采用试剂盒检测白细胞计数和中性粒细胞百分比、炎症因子及氧化应激水平; 采用蛋白印迹法检测Toll样受体(Toll-like receptor, TLR)信号通路相关蛋白水平。结果 对照组、模型组、多西环素组、左氧氟沙星组、联合组和oe-HtrA2组的HtrA2 mRNA表达分别为(1.00±0.16)、(2.31±0.29)、(1.76±0.17)、(1.81±0.26)、(1.37±0.14)和(3.89±0.58),TLR2蛋白水平分别为(1.00±0.20)、(3.65±0.60)、(2.88±0.43)、(2.74±0.65)、(1.87±0.21)和(2.92±0.49),TLR4蛋白水平分别为(1.00±0.17)、(3.92±0.71)、(2.77±0.54)、(2.81±0.43)、(2.06±0.28)和(3.11±0.44),髓样分化因子88(myeloid differentiation factor 88, MyD88)蛋白水平分别为(1.00±0.15)、(2.94±0.45)、(2.21±0.39)、(2.25±0.23)、(1.44±0.16)和(2.41±0.27)(P<0.05)。多西环素组和左氧氟沙星组HtrA2表达、白细胞计数及中性粒细胞百分比、炎症及氧化应激水平、TLR信号通路蛋白水平低于模型组,高于联合组; oe-HtrA2组与联合组结果相反。结论 多西环素联合左氧氟沙星改善CRAB肺炎大鼠肺部损伤,与调控HtrA2抑制TLR2/4-MyD88信号通路激活相关。

Abstract:

Objective To study the mechanism of doxycycline combined with levofloxacin in regulating high temperature requirement factor A2(HtrA2)for the treatment of rats with pneumonia caused by Carbapenem-resistant Acinetobacter Baumannii(CRAB). Methods Sixty SD rats were randomly divided into control group, model group, doxycycline group, levofloxacin group, combination group and overexpressed(oe)-HtrA2 group, with 10 rats in each group. In the model group, 100 μl 1×10¹¹ cfu/L AB5075 bacteria were dropped into the nasal cavity of rats; Doxycycline group was given 20 mg/kg doxycycline intragastric administration on the basis of model group. Levofloxacin group was given 30 mg/kg levofloxacin by gavage on the basis of model group. Based on the model group, the combined group was given 20 mg/kg doxycycline +30 mg/kg levofloxacin by intragastric administration; In group oe-HtrA2, HtrA2 lentivirus was injected into SD rats through the tail vein at 200 μl and 1×10⁹ IFU/L each time. Real-time fluorescence quantitative polymerase chain reaction was used to detect the expression of HtrA2 mRNA. The colony-forming unit method was employed to measure the bacterial content in lung tissues. Kits were utilized to detect white blood cell count, the percentage of neutrophils, the levels of inflammatory factors and oxidative stress. Western blotting was adopted to detect the levels of proteins related to the Toll-like receptor(TLR)signaling pathway. Results The expressions of HtrA2 mRNA in the control group, model group, doxycycline group, levofloxacin group, combination group and oe-HtrA2 group were(1.00±0.16),(2.31±0.29),(1.76±0.17),(1.81±0.26),(1.37±0.14)and(3.89±0.58)respectively. The protein levels of TLR2 in these groups were(1.00±0.20),(3.65±0.60),(2.88±0.43),(2.74±0.65),(1.87±0.21)and(2.92±0.49)respectively. The protein levels of TLR4 were(1.00±0.17),(3.92±0.71),(2.77±0.54),(2.81±0.43),(2.06±0.28)and(3.11±0.44)respectively. The protein levels of myeloid differentiation factor 88(MyD88)were(1.00±0.15),(2.94±0.45),(2.21±0.39),(2.25±0.23),(1.44±0.16)and(2.41±0.27)respectively. There were statistically significant differences in the above indicators(all P<0.05). Compared with the model group, the expressions of HtrA2, white blood cell counts, percentages of neutrophils, levels of inflammation and oxidative stress, and protein levels of the TLR signaling pathway in the doxycycline group and the levofloxacin group were all decreased. The combination group showed further improvement. Compared with the combination group, the results in the oe-HtrA2 group were the opposite. Conclusion The combination of doxycycline and levofloxacin can improve lung injury in rats with CRAB pneumonia, which may be related to the regulation of HtrA2 and the inhibition of the activation of the TLR2/4-MyD88 signaling pathway.

参考文献/References:

1 陶 春, 童 瑜, 王 旗, 等. 耐碳青霉烯类鲍曼不动杆菌颅内感染多途径应用多黏菌素类药物治疗的病例分析[J]. 医药导报, 2024, 43(10): 1583-1588.
2 Tamma PD, Aitken SL, Bonomo RA, et al. Infectious diseases society of america guidance on the treatment of ampc β-lactamase-producing enterobacterales, carbapenem-resistant acinetobacter baumannii, and Stenotrophomonas maltophilia Infections[J]. Clin Infect Dis, 2022, 74(12): 2089-2114.
3 庞茜茜, 刘 斐, 蒲洁琨, 等. 两种联合用药方案治疗耐碳青霉烯类鲍曼不动杆菌肺炎的效果及对炎症反应的影响[J]. 中国医院用药评价与分析, 2024, 24(2): 176-179.
4 Zhang DF, Zhang ZF, Li PD, et al. Characterization of carbapenem-resistant Acinetobacter baumannii ST540 and Klebsiella pneumoniae ST2237 isolates in a pneumonia case from China[J]. J Appl Microbiol, 2022, 133(3): 1434-1445.
5 Franzone JP, Mackow NA, van Duin D. Current treatment options for pneumonia caused by carbapenem-resistant Acinetobacter baumannii[J]. Curr Opin Infect Dis, 2024, 37(2): 137-143.
6 王月华, 鞠晓红. 棘阿米巴感染治疗药物的研究进展[J]. 医药导报, 2023, 42(9): 1363-1367.
7 吴 凡, 王保贵, 胡 文, 等. 多西环素联合左氧氟沙星对耐药肺炎克雷伯菌的体内外抗菌活性研究[J]. 中国新药杂志, 2023, 32(23): 2425-2433.
8 El-Ghali A, Kunz Coyne AJ, et al. Sulbactam-durlobactam: A novel β-lactam-β-lactamase inhibitor combination targeting carbapenem-resistant Acinetobacter baumannii infections[J]. Pharmacotherapy, 2023, 43(6): 502-513.
9 Wu L, Li X, Li Z, et al. HtrA serine proteases in cancers: A target of interest for cancer therapy[J]. Biomed Pharmacother, 2021, 139: 111603.
10 杨 阳, 任田田, 徐 鹏. 耐碳青霉烯类肺炎克雷伯菌感染治疗效果影响因素分析及预测模型建立[J/OL]. 现代疾病预防控制, 2024, 35(10): 726-731.
11 黄冬梅, 刘 军, 李福祥, 等. 四川省二级综合医院CRAB感染发生的相关危险因素分析[J/CD]. 中华肺部疾病杂志(电子版), 2020, 13(3): 355-359.
12 晁晓峰, 冯倚帆, 黄天宁, 等. 颅脑术后继发颅内多重耐药鲍曼不动杆菌感染的危险因素[J].中国临床神经外科杂志, 2022, 27(6): 471-473.
13 段 炜, 范沁林, 刘 勇. 替加环素对NICU碳青霉烯耐药菌致院内获得性肺炎抗感染疗效的回顾性分析[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(3): 315-320.
14 Zha L, Zhang X, Cheng Y, et al. Intravenous Polymyxin b as adjunctive therapy to high-dose tigecycline for the treatment of nosocomial pneumonia due to carbapenem-resistant acinetobacter baumannii and klebsiella pneumoniae: a propensity score-matched cohort study[J]. Antibiotics(Basel), 2023, 12(2): 273.
15 黄育波, 周宇麒, 郑文争, 等. 多重耐药鲍曼不动杆菌外排泵与外膜蛋白表达水平分析[J].实用医学杂志, 2023, 39(16): 2122-2129.
16 Deng Y, Chen L, Yue M, et al. Sulbactam combined with tigecycline improves outcomes in patients with severe multidrug-resistant Acinetobacter baumannii pneumonia[J]. BMC Infect Dis, 2022, 22(1): 795.
17 罗 丹, 李玉良, 翁邦碧, 等. 鲍曼不动杆菌快速表型药敏检测方法的建立和初步应用[J]. 第三军医大学学报, 2021, 43(18): 1775-1782.
18 王保贵, 王娜娜, 周思绪, 等. 多西环素联合利福平对耐碳青霉烯类肺炎克雷伯菌体内外抗菌活性[J]. 中国抗生素杂志, 2023, 48(10): 1183-1191.
19 Sitovs A, Sartini I, Giorgi M. Levofloxacin in veterinary medicine: a literature review[J]. Res Vet Sci, 2021, 137: 111-126.
20 Aslam HM, Sohail A, Shahid A, et al. Levofloxacin induces erythrocyte contraction leading to red cell death[J]. Drug Target Insights, 2024,18: 78-83.
21 陈苏维, 艾雪言, 刘 晔, 等. 盘基网柄菌基网柄菌HtrA2基因的克隆与生物信息学分析[J]. 安康学院学报, 2022, 34(4): 123-128.
22 Feng L, Li Z, Xiong Y, et al. HtrA2 independently predicts poor prognosis and correlates with immune cell infiltration in hepatocellular carcinoma[J]. J Oncol, 2023, 4067418.
23 Tian Z, Zhao J, Wang Y. The prognostic value of TPM1-4 in hepatocellular carcinoma[J]. Cancer Med, 2022, 11(2): 433-446.
24 柴 媛, 王俊瑞, 英 兰, 等. BALB/c大鼠多重耐药鲍曼不动杆菌肺部感染模型的建立和评估[J]. 微生物与感染, 2022, 17(2): 71-80.
25 张 阳, 焦雨佼, 巩翠珂, 等. 慢阻肺患者鲍曼不动杆菌感染肺泡巨噬细胞凋亡机制的研究[J]. 中国病原生物学杂志, 2022, 17(9): 1082-1085.
26 陶兴茹, 段彦彦, 董丽丽, 等. 左氧氟沙星和多西环素治疗儿童难治性支原体肺炎的安全性和有效性分析[J]. 中南药学, 2021, 19(5): 1025-1028.
27 Xu Z, Lin J, Xie Y, et al. HtrA2 is required for inflammatory responses in BMDMs via controlling TRAF2 stability in collagen-induced arthritis[J]. Mol Immunol, 2021, 129: 78-85.
28 何谷良, 吴 涛, 卢芳国, 等. 麻杏石甘汤对流感病毒肺部感染模型肺组织TLR2/4-MyD88信号通路蛋白表达的影响[J]. 中华中医药杂志, 2022, 37(1): 435-440.
29 Gong Z, Zhang J, Zhang S, et al. TLR2, TLR4, and NLRP3 mediated the balance between host immune-driven resistance and tolerance in Staphylococcus aureus-infected mice[J]. Microb Pathog, 2022, 169: 105671.
30 严宝飞, 戴仕林, 刘圣金, 等. 黄芩汤对非酒精性脂肪肝炎大鼠的作用及机制研究[J]. 中国医院药学杂志, 2022, 42(10): 1009-1014.

备注/Memo

备注/Memo:

基金项目: 河北省卫健委医学科学课题研究计划(20231455)
北京医卫健康公益基金会医学科学研究基金资助项目(ZL007HB)
通信作者: 刘克勤, Email: liukeqin1@hbbfyfy.com

常用功能

更新日期/Last Update: 2025-02-20